[
  {
    "ts": null,
    "headline": "Axsome (AXSM) Down 0.8% Since Last Earnings Report: Can It Rebound?",
    "summary": "Axsome (AXSM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
    "url": "https://finnhub.io/api/news?id=86ea023229c5572821648691a4270ce4d51a9b631037fdfc87d2c9526ac2e02d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742484626,
      "headline": "Axsome (AXSM) Down 0.8% Since Last Earnings Report: Can It Rebound?",
      "id": 133327023,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BIIB",
      "source": "Yahoo",
      "summary": "Axsome (AXSM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
      "url": "https://finnhub.io/api/news?id=86ea023229c5572821648691a4270ce4d51a9b631037fdfc87d2c9526ac2e02d"
    }
  },
  {
    "ts": null,
    "headline": "Q4 Rundown: Biogen (NASDAQ:BIIB) Vs Other Therapeutics Stocks",
    "summary": "Let’s dig into the relative performance of Biogen (NASDAQ:BIIB) and its peers as we unravel the now-completed Q4 therapeutics earnings season.",
    "url": "https://finnhub.io/api/news?id=661997f746daf698d0000c7f7328d3e6c49fc655d722e02e6e14965810a8bc71",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742461970,
      "headline": "Q4 Rundown: Biogen (NASDAQ:BIIB) Vs Other Therapeutics Stocks",
      "id": 133325405,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BIIB",
      "source": "Yahoo",
      "summary": "Let’s dig into the relative performance of Biogen (NASDAQ:BIIB) and its peers as we unravel the now-completed Q4 therapeutics earnings season.",
      "url": "https://finnhub.io/api/news?id=661997f746daf698d0000c7f7328d3e6c49fc655d722e02e6e14965810a8bc71"
    }
  }
]